Say Goodbye to IUI.
Say hello to FemaSeed.

The next generation of artificial insemination is here.

> 2x

more effective than IUI*

Read Topline Data *Based on per-cycle pregnancy rates in male factor infertility

Enhancing natural fertilization with innovative technology.

An icon of three sperm representing the word Direct. Targeted
An icon of a shield representing Safe. Safe
An icon of an award ribbon representing the word Reliable. Effective
An icon of a coin floating above an upturned hand representing Cost-Effective. Affordable
Learn More

FemaSeed is an intratubal insemination approach
without catheterization.


FemaSeed delivers washed sperm precisely into the selected fallopian tube by placement of a balloon catheter directly in the uterine cornu.  FemaSeed can be rotated to deliver sperm to the contralateral tube.

FemaSeed allows for expansion of practice services with a safe & affordable first-line infertility solution with improved efficacy demonstrated over historic IUI for low male sperm count.

Learn More

Clinical Data

Trial Design: Prospective, multi-center, unblinded pivotal clinical trial with historical control. Conducted under FDA Investigational Device Exemption (IDE) approval. (NCT0468847)

Top-Line Results1:

PRIMARY ENDPOINT
(for male-factor/unexplained fertility (1-20 million total motile sperm count, TMSC))
  • Pregnancy rate was 26.3% by subject (n=38) and 17.5% by cycle (n=57)
    • FemaSeed demonstrated a significantly higher pregnancy rate than the historical control
    (6.7% pregnancy rate by cycle for intrauterine insemination (IUI) with male factor (greater than 1 million TMSC))

    SAFETY
  • Adverse events were consistent with IUI.
    • 1. Liu, J. H., Glassner, M., Gracia, C. R., Johnstone, E. B., Schnell, V. L., Thomas, M. A., Morrison, L., Lee-Sepsick, K. (2024). FemaSeed Directional Intratubal Artificial Insemination for Couples with Male-Factor or Unexplained Infertility Associated with Low Male Sperm Count. J Gynecol Reprod Med, 8(2), 01-12.

    Market Research

    Number of participants: 1,000 infertile women
  • More than 7 in 10 women were extremely or very likely to consider insemination with FemaSeed
  • For those who received IVF, 88% would have preferred FemaSeed prior to moving on to IVF
  • 85% who received IUI would have preferred FemaSeed instead of IUI

    • Millions of women and couples struggle with infertility1


    Only a fraction pursue treatment for various reasons, including economic barriers or emotional burden.



    Consider FemaSeed Intratubal Insemination as a First-Line Treatment Option for:


    An icon representing a man and a woman.
    An icon representing two women.
    An icon of three sperm with a line through them to represent no exposure to sperm.

    1 https://www.cdc.gov/nchs/nsfg/key_statistics/i-keystat.htm

    FemaSeed Online Training


    Learn how to perform the FemaSeed procedure at your convenience. Our FemaSeed online training platform details the procedure step-by-step and provides valuable resources.

    Learn Now
    A computer monitor displaying FemaSeed training interface on LearnUpon.
    © 2024 Femasys Inc. All rights reserved. FemaSeed and StopLock are registered trademarks of Femasys Inc. | Terms of Use | Privacy Policy